OPKO HEALTH INC(NASDAQ:OPK) stock News

OPK Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Labcorp Holdings Inc - Mentions: LH

Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

2 months ago - By: Yahoo Finance - Mentions: MRK

OPKO Health (OPK) Advances EBV Vaccine and GLP-1 Pipeline While Streamlining Diagnostics

2 months ago - By: The Motley Fool - Mentions: PFE

OPKO Health (OPK) Q2 2025 Earnings Call Transcript

3 months ago - By: The Motley Fool

Opko Health (OPK) Q2 Revenue Falls 14%

3 months ago - By: Benzinga - Mentions: BSAC BGC RMNI MTZ ...

Earnings Scheduled For July 31, 2025

6 months ago - By: Benzinga - Mentions: AVB CMPR PPL LANC ...

Earnings Scheduled For April 30, 2025

3 months ago - By: Zacks Investment Research - Mentions: BSX WST GEHC

OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands

3 months ago - By: Yahoo Finance

OPKO Health (OPK) to Present Short Bowel Syndrome Treatment in Prague

3 months ago - By: Zacks Investment Research

Compared to Estimates, OPKO Health (OPK) Q2 Earnings: A Look at Key Metrics

3 months ago - By: Zacks Investment Research - Mentions: SRTS

OPKO Health (OPK) Reports Q2 Loss, Lags Revenue Estimates

3 months ago - By: OPKO Health, Inc.

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results

3 months ago - By: Yahoo Finance - Mentions: MA

H.C. Wainwright Reiterates a Buy Rating on Opko Health (OPK), Keeps the PT at $3

4 months ago - By: NextPlat Corp. - Mentions: NXPL

NextPlat Issues Interim CEO Update Shareholder Letter

4 months ago - By: Yahoo Finance - Mentions: GS ENTX

OPKO Health (OPK) to Present OPK-88006 Data at ENDO 2025

4 months ago - By: OPKO Health, Inc.

OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium

4 months ago - By: OPKO Health, Inc.

OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting

4 months ago - By: Yahoo Finance - Mentions: ATAI ENTX

Piper Sandler Reiterates a Buy Rating on Opko Health (OPK) With a $3 PT

4 months ago - By: OPKO Health, Inc.

OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development

6 months ago - By: Zacks Investment Research - Mentions: BSX ITGR EHC

OPK Stock Slips Following Q1 Earnings Miss, Gross Margin Expands

6 months ago - By: Zacks Investment Research

OPKO Health (OPK) Reports Q1 Earnings: What Key Metrics Have to Say

6 months ago - By: Zacks Investment Research - Mentions: TCMD

OPKO Health (OPK) Reports Q1 Loss, Lags Revenue Estimates

6 months ago - By: OPKO Health, Inc.

OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results

6 months ago - By: Zacks Investment Research

Down -24.31% in 4 Weeks, Here's Why OPKO Health (OPK) Looks Ripe for a Turnaround

6 months ago - By: Stocktwits - Mentions: NXPL IWC BABA

This Nano-Cap E-Commerce Play Saw 3,100% Jump In Retail Chatter Last Week: What's Behind The Surge?

6 months ago - By: NextPlat Corp. - Mentions: NXPL

NextPlat Provides Statement on U.S. Tariff Impact on its E-Commerce Development Program

7 months ago - By: OPKO Health, Inc.

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

7 months ago - By: Yahoo Finance - Mentions: FDS COMP MDGL GIS ...

Is FactSet Research Systems (FDS) The Most Expensive Stock Insiders Are Dumping In March?

7 months ago - By: Labcorp Holdings Inc - Mentions: LH

OPKO HEALTH INC (OPK) Stock News

OPK Latest News, Press Relases and Analysis

Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

OPKO Health (OPK) Advances EBV Vaccine and GLP-1 Pipeline While Streamlining Diagnostics

OPKO Health (OPK) Q2 2025 Earnings Call Transcript

Opko Health (OPK) Q2 Revenue Falls 14%

Earnings Scheduled For July 31, 2025

Earnings Scheduled For April 30, 2025

OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands

OPKO Health (OPK) to Present Short Bowel Syndrome Treatment in Prague

Compared to Estimates, OPKO Health (OPK) Q2 Earnings: A Look at Key Metrics

OPKO Health (OPK) Reports Q2 Loss, Lags Revenue Estimates

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results

H.C. Wainwright Reiterates a Buy Rating on Opko Health (OPK), Keeps the PT at $3

NextPlat Issues Interim CEO Update Shareholder Letter

OPKO Health (OPK) to Present OPK-88006 Data at ENDO 2025

OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium

OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting

Piper Sandler Reiterates a Buy Rating on Opko Health (OPK) With a $3 PT

OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development

OPK Stock Slips Following Q1 Earnings Miss, Gross Margin Expands

OPKO Health (OPK) Reports Q1 Earnings: What Key Metrics Have to Say

OPKO Health (OPK) Reports Q1 Loss, Lags Revenue Estimates

OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results

Down -24.31% in 4 Weeks, Here's Why OPKO Health (OPK) Looks Ripe for a Turnaround

This Nano-Cap E-Commerce Play Saw 3,100% Jump In Retail Chatter Last Week: What's Behind The Surge?

NextPlat Provides Statement on U.S. Tariff Impact on its E-Commerce Development Program

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

Is FactSet Research Systems (FDS) The Most Expensive Stock Insiders Are Dumping In March?

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses